These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3547055

  • 21. [Clinical experience with norfloxacin in urinary tract infections in gynecology].
    Angelini A, Mariucci A, Goracci P.
    Clin Ter; 1986 Jun 15; 117(5):383-5. PubMed ID: 3742960
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical experience of norfloxacin (Baccidal) in the urological field].
    Fukuoka H, Goto A, Sasaki S.
    Hinyokika Kiyo; 1985 Sep 15; 31(9):1667-74. PubMed ID: 4083223
    [Abstract] [Full Text] [Related]

  • 23. Case report of renal failure during norfloxacin therapy.
    Boelaert J, de Jaegere PP, Daneels R, Schurgers M, Gordts B, van Landuyt HW.
    Clin Nephrol; 1986 May 15; 25(5):272. PubMed ID: 3522001
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y, Funaki H, Takagane H, Tanji S, Abe T, Aoki H, Kubo T, Ohori T.
    Hinyokika Kiyo; 1985 Aug 15; 31(8):1501-17. PubMed ID: 4083210
    [Abstract] [Full Text] [Related]

  • 25. Treatment of urinary tract infection with norfloxacin. Analysis of cost.
    Ramirez-Ronda C, Colon M, Saavedra S, Sabbaj J, Corrado ML.
    Am J Med; 1987 Jun 26; 82(6B):75-8. PubMed ID: 3300315
    [Abstract] [Full Text] [Related]

  • 26. Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.
    Corrado ML, Grad C, Sabbaj J.
    Am J Med; 1987 Jun 26; 82(6B):70-4. PubMed ID: 3300314
    [Abstract] [Full Text] [Related]

  • 27. Norfloxacin in acute urinary tract infections.
    Deaney NB, Vogel R, Vandenburg MJ, Currie WJ.
    Practitioner; 1984 Jan 26; 228(1387):111-7. PubMed ID: 6229726
    [No Abstract] [Full Text] [Related]

  • 28. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
    Pummer K.
    Am J Med; 1993 Mar 22; 94(3A):108S-113S. PubMed ID: 8452165
    [Abstract] [Full Text] [Related]

  • 29. [Norfloxacin: hepatic tolerance].
    Tarantino G, Cambri S, Pannain M.
    Clin Ter; 1986 Dec 31; 119(6):471-4. PubMed ID: 3816117
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of urinary infections: clinical perspectives.
    Fontana G, Laudi M, Carlone NA, Savoia D.
    Chemioterapia; 1987 Feb 31; 6(1):45-9. PubMed ID: 3549009
    [Abstract] [Full Text] [Related]

  • 31. Norfloxacin treatment in urinary tract infections by urease-producing bacteria accompanying renal calculi. Our experience.
    Muzzonigro G, Caraceni E, Baldassari M, Ippoliti L, Polito M.
    Acta Urol Belg; 1985 Feb 31; 53(4):724-9. PubMed ID: 4091116
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical study of NFLX (norfloxacin) in complicated urinary tract infections].
    Murase T, Mitsuya H, Fukatsu H, Yoshida K, Natsume H, Obata K, Ohshima S, Asaka H, Kobayashi M, Okamura K.
    Hinyokika Kiyo; 1986 Aug 31; 32(8):1167-75. PubMed ID: 3788743
    [Abstract] [Full Text] [Related]

  • 33. The use of norfloxacin in a university hospital.
    Alaniz C, Stumpf JL, Townsend KA.
    Hosp Pharm; 1991 Aug 31; 26(8):707-10, 719. PubMed ID: 10112581
    [Abstract] [Full Text] [Related]

  • 34. Susceptibility testing of urinary tract pathogens to norfloxacin.
    Andrews JM, Wise R.
    J Antimicrob Chemother; 1991 Aug 31; 28(2):309-11. PubMed ID: 1778861
    [No Abstract] [Full Text] [Related]

  • 35. Use of the new quinolones during pregnancy.
    Koren G.
    Can Fam Physician; 1996 Jun 31; 42():1097-9. PubMed ID: 8704483
    [No Abstract] [Full Text] [Related]

  • 36. Norfloxacin-induced nephrotic syndrome.
    Hestin D, Hanesse B, Frimat L, Renaudin JM, Netter P, Kessler M.
    Lancet; 1995 Mar 18; 345(8951):732-3. PubMed ID: 7885154
    [No Abstract] [Full Text] [Related]

  • 37. [Study of a national survey to evaluate the in vitro activity of norfloxacin and 6 other antibiotics against urinary pathogens].
    Román Pumar JL.
    Med Clin (Barc); 1986 May 03; 86(17):741. PubMed ID: 3736169
    [No Abstract] [Full Text] [Related]

  • 38. Exacerbation of myasthenia gravis by norfloxacin.
    Rauser EH, Ariano RE, Anderson BA.
    DICP; 1990 Feb 03; 24(2):207-8. PubMed ID: 2309517
    [No Abstract] [Full Text] [Related]

  • 39. Norfloxacin: targeted antibiotic therapy. Proceedings of a workshop. Taormina, Sicily, 11 April 1986.
    Scand J Infect Dis Suppl; 1986 Feb 03; 48():1-91. PubMed ID: 3465029
    [No Abstract] [Full Text] [Related]

  • 40. Norfloxacin-induced hepatitis.
    Davoren P, Mainstone K.
    Med J Aust; 1993 Sep 20; 159(6):423, 426. PubMed ID: 8377697
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.